- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/48 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 263/48
Total number of patents in this class: 183
10-year publication summary
|
21
|
16
|
22
|
13
|
14
|
9
|
11
|
7
|
11
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sareum Limited | 20 |
12 |
| Cytokinetics, Inc. | 251 |
7 |
| Epigen Biosciences, Inc. | 13 |
7 |
| Oryzon Genomics S.A. | 103 |
5 |
| Romark Laboratories L.C. | 43 |
4 |
| Shionogi & Co., Ltd. | 885 |
4 |
| Lifearc | 48 |
4 |
| Bayer Cropscience AG | 1833 |
3 |
| DSM IP Assets B.V. | 5386 |
3 |
| The General Hospital Corporation | 4881 |
3 |
| Dompé Farmaceutici S.p.A. | 302 |
3 |
| Japan Tobacco Inc. | 3569 |
3 |
| Max-delbruck-centrum fur Molekulare Medizin | 46 |
3 |
| Plexxikon Inc. | 146 |
3 |
| Omeicos Therapeutics GmbH | 8 |
3 |
| Exonate Limited | 15 |
3 |
| Desai, Laxman S. | 3 |
3 |
| Libra Therapeutics, Inc. | 12 |
3 |
| Bristol-myers Squibb Company | 4757 |
2 |
| The Regents of the University of California | 20868 |
2 |
| Other owners | 103 |